I want your take on the recent oncology drug shortage we are experiencing now. Drugs like cytarabine, leucovorin, thiotepa, etoposide, bleomycin, doxorubicin, and cisplatin. During our last GI tumor board meeting, I heard about clinics in the midwest complaining about shortage of 5FU. Im concern about inadequate substitutions, inadequate alternatives and rationing. Its hard for me to explain to a patient that I can not give them X drug because they are not enrolled in a clinical trial or that they are not being treated adjuvantly. It distresses the patients and it worries me.
Whats your take on this situation?
I thought you might find this interesting http://www.cancer.org/Cancer/news/Ne...s-and-patients
So do we have a shortage of drugs like 5FU and leucovorin because the manufacturers want to transition us to newer and more profitable drugs? What? How about let the MDs and patients decide which drug regime they use rather than have it force fed them by big pharma.
Last edit by tewdles on Sep 14, '11